Bio-Rad Laboratories - 39 Year Stock Split History | BIO

Stock split history for Bio-Rad Laboratories since 1980. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Bio-Rad Laboratories Annual Stock Splits
Bio-Rad Laboratories Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $9.957B $2.290B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.330B 27.69
Medtronic (MDT) Ireland $146.309B 20.54
Stryker (SYK) United States $80.541B 27.85
Boston Scientific (BSX) United States $58.421B 28.34
Baxter (BAX) United States $44.378B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.384B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.264B 18.09
Lonza Group Ag (LZAGY) Switzerland $24.906B 0.00
Coloplast (CLPBY) Denmark $24.894B 39.74
Terumo (TRUMY) Japan $22.254B 25.59
Smith & Nephew SNATS (SNN) United Kingdom $20.394B 0.00
ResMed (RMD) United States $18.779B 35.81
Sunny Optical Technology (SNPTF) China $16.365B 0.00
Canopy Growth (CGC) Canada $9.657B 0.00
Insulet (PODD) United States $8.625B 511.07
Perrigo (PRGO) Ireland $7.714B 14.21
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.923B 20.64
Haemonetics (HAE) United States $6.394B 48.25
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.561B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.233B 0.00
Neogen (NEOG) United States $4.125B 68.48
NuVasive (NUVA) United States $3.402B 27.12
ICU Medical (ICUI) United States $3.401B 22.06
Hutchison China MediTech (HCM) China $2.728B 0.00
Quidel (QDEL) United States $2.681B 26.62
Agios Pharmaceuticals (AGIO) United States $2.216B 0.00
National Vision Holdings (EYE) United States $2.181B 47.07
Cardiovascular Systems (CSII) United States $1.821B 0.00
Aphria (APHA) $1.659B 0.00
VAREX IMAGING (VREX) United States $1.115B 25.70
AtriCure (ATRC) United States $0.998B 0.00
Lantheus Holdings (LNTH) United States $0.977B 25.69
Omeros (OMER) United States $0.949B 0.00
Phibro Animal Health (PAHC) United States $0.894B 14.54
Eagle Pharmaceuticals (EGRX) United States $0.803B 20.47
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.763B 18.03
Cerus (CERS) United States $0.755B 0.00
LeMaitre Vascular (LMAT) United States $0.702B 41.63
MacroGenics (MGNX) United States $0.652B 0.00
Surmodics (SRDX) United States $0.640B 121.56
Quanterix (QTRX) United States $0.638B 0.00
TG Therapeutics (TGTX) United States $0.624B 0.00
OraSure Technologies (OSUR) United States $0.469B 21.71
Meridian Bioscience (VIVO) United States $0.427B 13.32
BioLife Solutions (BLFS) United States $0.392B 128.81
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.391B 0.00
Owens & Minor (OMI) United States $0.378B 11.32
Utah Medical Products (UTMD) United States $0.370B 27.14
United Health Products (UEEC) United States $0.330B 0.00
Zynex (ZYXI) United States $0.290B 30.83
Bovie Medical (APYX) United States $0.243B 0.00
Rockwell Medical (RMTI) United States $0.204B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Vapotherm (VAPO) United States $0.165B 0.00
Fonar (FONR) United States $0.150B 10.69
Chimerix (CMRX) United States $0.141B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.087B 20.54
MRI Interventions (MRIC) United States $0.067B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
Nephros (NEPH) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00